Medifast, Inc. reported a significant decline in its financial performance for the fiscal year ended December 31, 2025, with total revenue falling to $385.8 million, a decrease of 36% from $602.5 million in 2024. This decline was primarily attributed to a reduction in the number of active earning coaches, which dropped by 40.6% to approximately 16,100 from 27,100 in the previous year. The average revenue per active earning coach, however, increased by 6.2% to $4,664, indicating improved productivity among the remaining coaches. The company's net loss for the year was $18.7 million, compared to a net income of $2.1 million in 2024.
In response to the challenging market conditions, including the rapid adoption of GLP-1 medications for weight loss, Medifast has initiated a strategic transformation focusing on holistic metabolic health. This includes the introduction of Metabolic Synchronization™, a new approach aimed at reversing metabolic dysfunction. The company plans to launch significant product innovations in 2026, incorporating next-generation ingredients to enhance metabolic health. Additionally, Medifast has made organizational changes to improve coach productivity and expand its coach network, which is seen as critical for future growth.
Operationally, Medifast's cost of sales decreased by 29.9% to $110.6 million, reflecting lower sales volumes. Gross profit also fell by 38.1% to $275.2 million, with gross profit margins declining to 71.3% from 73.8% in the previous year. Selling, general, and administrative expenses were reduced by 34.5% to $289.4 million, primarily due to lower coach compensation and marketing expenses. Despite these reductions, the company reported a loss from operations of $14.2 million, compared to a profit of $2.9 million in 2024.
Looking ahead, Medifast is focused on enhancing its digital tools and client experience to improve coach productivity and client acquisition. The company aims to reactivate former clients and attract new ones through its popular product lines, including OPTAVIA ASCEND and OPTAVIA ACTIVE. The management believes that the coach-based model is scalable and represents a competitive advantage in the weight management market. However, the company acknowledges the ongoing macroeconomic challenges, including inflation and changes in consumer spending behavior, which may impact future performance.
As of December 31, 2025, Medifast had stockholders' equity of $198.9 million and working capital of $158.7 million. The company has discontinued its quarterly cash dividend to support investments in technology and future growth initiatives. Medifast's leadership remains committed to navigating the evolving landscape of the metabolic health market, leveraging its scientific heritage and community support to drive sustainable growth in the coming years.
About MEDIFAST INC
Medifast, Inc. is a health and wellness company specializing in coach-guided lifestyle programs, primarily through its OPTAVIA brand. It offers personalized coaching, scientifically designed nutrition plans, and community support to help individuals achieve sustainable weight loss and improved health. The company integrates medical solutions, including GLP-1 medications, and operates a scalable, coach-centric business model targeting the growing global wellness market.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.